Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study

Background: Acquired brain injury can cause disorders of consciousness. An additive effect of cerebrolysin and amantadine has been postulated, but not systematically studied. The present study aimed to investigate this additive effect in patients with disorders of consciousness secondary to acquired...

Full description

Bibliographic Details
Main Authors: Seunghwan Lee, Hyun Haeng Lee, Yejin Lee, Jongmin Lee
Format: Article
Language:English
Published: Medical Journals Sweden 2020-02-01
Series:Journal of Rehabilitation Medicine
Subjects:
Online Access: https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2654
_version_ 1818907442239504384
author Seunghwan Lee
Hyun Haeng Lee
Yejin Lee
Jongmin Lee
author_facet Seunghwan Lee
Hyun Haeng Lee
Yejin Lee
Jongmin Lee
author_sort Seunghwan Lee
collection DOAJ
description Background: Acquired brain injury can cause disorders of consciousness. An additive effect of cerebrolysin and amantadine has been postulated, but not systematically studied. The present study aimed to investigate this additive effect in patients with disorders of consciousness secondary to acquired brain injury. Methods: The medical records of patients diagnosed with disorders of consciousness after acquired brain injury were reviewed. The patients were categorized into 2 groups: single regimen (amantadine only) and dual regimen (amantadine plus cerebrolysin). The patients’ conscious states were assessed using the Coma Recovery Scale-Revised (CRS-R) before, and after 4 weeks of drug administration. Results: Data for a total of 84 patients were analysed. The degree of change in CRS-R and the proportion of patients in the disorders of consciousness category showing a change was higher in the dual regimen group than in the single regimen group. Analysis of patients who had initially been in a prolonged vegetative state or minimally conscious state minus before administration showed that the patients in the dual regimen group had greater increases in CRS-R scores than those in the single regimen group. Conclusion: This study identified that an amantadine-plus-cerebrolysin regimen additively affects patients with prolonged disorders of consciousness. A future controlled trial is needed to investigate the efficacy of each regimen in patients with prolonged disorders of consciousness secondary to acquired brain injury, particularly for patients who have remained in a prolonged vegetative state after acquired brain injury.
first_indexed 2024-12-19T21:55:11Z
format Article
id doaj.art-10a9353a7d484c2881f5cdf1a1764950
institution Directory Open Access Journal
issn 1650-1977
1651-2081
language English
last_indexed 2024-12-19T21:55:11Z
publishDate 2020-02-01
publisher Medical Journals Sweden
record_format Article
series Journal of Rehabilitation Medicine
spelling doaj.art-10a9353a7d484c2881f5cdf1a17649502022-12-21T20:04:18ZengMedical Journals SwedenJournal of Rehabilitation Medicine1650-19771651-20812020-02-01522jrm0002510.2340/16501977-26542626Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control studySeunghwan Lee0Hyun Haeng LeeYejin LeeJongmin Lee Department of Rehabilitation Medicine, Konkuk University School of Medicine and Konkuk University Medical Center, Korea. Background: Acquired brain injury can cause disorders of consciousness. An additive effect of cerebrolysin and amantadine has been postulated, but not systematically studied. The present study aimed to investigate this additive effect in patients with disorders of consciousness secondary to acquired brain injury. Methods: The medical records of patients diagnosed with disorders of consciousness after acquired brain injury were reviewed. The patients were categorized into 2 groups: single regimen (amantadine only) and dual regimen (amantadine plus cerebrolysin). The patients’ conscious states were assessed using the Coma Recovery Scale-Revised (CRS-R) before, and after 4 weeks of drug administration. Results: Data for a total of 84 patients were analysed. The degree of change in CRS-R and the proportion of patients in the disorders of consciousness category showing a change was higher in the dual regimen group than in the single regimen group. Analysis of patients who had initially been in a prolonged vegetative state or minimally conscious state minus before administration showed that the patients in the dual regimen group had greater increases in CRS-R scores than those in the single regimen group. Conclusion: This study identified that an amantadine-plus-cerebrolysin regimen additively affects patients with prolonged disorders of consciousness. A future controlled trial is needed to investigate the efficacy of each regimen in patients with prolonged disorders of consciousness secondary to acquired brain injury, particularly for patients who have remained in a prolonged vegetative state after acquired brain injury. https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2654 cerebrolysin amantadine disorders of consciousness acquired brain injury responsiveness
spellingShingle Seunghwan Lee
Hyun Haeng Lee
Yejin Lee
Jongmin Lee
Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
Journal of Rehabilitation Medicine
cerebrolysin
amantadine
disorders of consciousness
acquired brain injury
responsiveness
title Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
title_full Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
title_fullStr Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
title_full_unstemmed Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
title_short Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
title_sort additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury a retrospective case control study
topic cerebrolysin
amantadine
disorders of consciousness
acquired brain injury
responsiveness
url https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2654
work_keys_str_mv AT seunghwanlee additiveeffectofcerebrolysinandamantadineondisordersofconsciousnesssecondarytoacquiredbraininjuryaretrospectivecasecontrolstudy
AT hyunhaenglee additiveeffectofcerebrolysinandamantadineondisordersofconsciousnesssecondarytoacquiredbraininjuryaretrospectivecasecontrolstudy
AT yejinlee additiveeffectofcerebrolysinandamantadineondisordersofconsciousnesssecondarytoacquiredbraininjuryaretrospectivecasecontrolstudy
AT jongminlee additiveeffectofcerebrolysinandamantadineondisordersofconsciousnesssecondarytoacquiredbraininjuryaretrospectivecasecontrolstudy